These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21179461)

  • 1. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates.
    Koren G; Korn L
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals.
    Lucke JC; Bell SK; Partridge BJ; Hall WD
    EMBO Rep; 2011 Mar; 12(3):197-201. PubMed ID: 21311560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
    Sahakian BJ; Morein-Zamir S
    Lancet Psychiatry; 2015 Apr; 2(4):357-62. PubMed ID: 26360089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.
    Franke AG; Papenburg C; Schotten E; Reiner PB; Lieb K
    BMC Fam Pract; 2014 Jan; 15():3. PubMed ID: 24397728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
    Kapur A
    CNS Drugs; 2020 Oct; 34(10):1045-1062. PubMed ID: 32794136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
    Repantis D; Bovy L; Ohla K; Kühn S; Dresler M
    Psychopharmacology (Berl); 2021 Feb; 238(2):441-451. PubMed ID: 33201262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of physicians' prescribing behaviour of methylphenidate for cognitive enhancement.
    Ponnet K; Wouters E; Van Hal G; Heirman W; Walrave M
    Psychol Health Med; 2014; 19(3):286-95. PubMed ID: 23713799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search of optimal psychoactivation: stimulants as cognitive performance enhancers.
    Rozenek EB; Górska M; Wilczyńska K; Waszkiewicz N
    Arh Hig Rada Toksikol; 2019 Sep; 70(3):150-159. PubMed ID: 32597132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.
    Bagot KS; Kaminer Y
    Addiction; 2014 Apr; 109(4):547-57. PubMed ID: 24749160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of methylphenidate use by healthy medical students and doctors in South Africa.
    Beyer C; Staunton C; Moodley K
    BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement.
    Alam N; Choudhary K
    Metab Brain Dis; 2018 Jun; 33(3):893-906. PubMed ID: 29470766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reining in the pharmacological enhancement train: we should remain vigilant about regulatory standards for prescribing controlled substances.
    Drabiak-Syed K
    J Law Med Ethics; 2011; 39(2):272-9. PubMed ID: 21561522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes Toward Cognitive Enhancer Use Among New Zealand Tertiary Students.
    Ram SS; Hussainy S; Henning M; Stewart K; Jensen M; Russell B
    Subst Use Misuse; 2017 Sep; 52(11):1387-1392. PubMed ID: 28429997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?
    Maier LJ; Wunderli MD; Vonmoos M; Römmelt AT; Baumgartner MR; Seifritz E; Schaub MP; Quednow BB
    PLoS One; 2015; 10(6):e0129805. PubMed ID: 26107846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
    Bisagno V; González B; Urbano FJ
    Pharmacol Res; 2016 Jul; 109():108-18. PubMed ID: 26826399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Professionals' attitudes towards the use of cognitive enhancers in academic settings.
    Ram SS; Russell B; Kirkpatrick C; Stewart K; Scahill S; Henning M; Curley L; Hussainy S
    PLoS One; 2020; 15(11):e0241968. PubMed ID: 33216781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The likelihood of cognitive enhancement.
    Lynch G; Palmer LC; Gall CM
    Pharmacol Biochem Behav; 2011 Aug; 99(2):116-29. PubMed ID: 21215768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.
    Franke AG; Gränsmark P; Agricola A; Schühle K; Rommel T; Sebastian A; Balló HE; Gorbulev S; Gerdes C; Frank B; Ruckes C; Tüscher O; Lieb K
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):248-260. PubMed ID: 28119083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.